Modelling the cost-effectiveness of a rapid diagnostic test (IgMFA) for uncomplicated typhoid fever in Cambodia

Mari Kajiwara Saito, Christopher M Parry and Shunmay Yeung

PLOS Neglected Tropical Diseases, 2018, vol. 12, issue 11, 1-18

Abstract: Typhoid fever is a common cause of fever in Cambodian children but diagnosis and treatment are usually presumptive owing to the lack of quick and accurate tests at an initial consultation. This study aimed to evaluate the cost-effectiveness of using a rapid diagnostic test (RDT) for typhoid fever diagnosis, an immunoglobulin M lateral flow assay (IgMFA), in a remote health centre setting in Cambodia from a healthcare provider perspective. A cost-effectiveness analysis (CEA) with decision analytic modelling was conducted. We constructed a decision tree model comparing the IgMFA versus clinical diagnosis in a hypothetical cohort with 1000 children in each arm. The costs included direct medical costs only. The eligibility was children (≤14 years old) with fever. Time horizon was day seven from the initial consultation. The number of treatment success in typhoid fever cases was the primary health outcome. The number of correctly diagnosed typhoid fever cases (true-positives) was the intermediate health outcome. We obtained the incremental cost effectiveness ratio (ICER), expressed as the difference in costs divided by the difference in the number of treatment success between the two arms. Sensitivity analyses were conducted. The IgMFA detected 5.87 more true-positives than the clinical diagnosis (38.45 versus 32.59) per 1000 children and there were 3.61 more treatment successes (46.78 versus 43.17). The incremental cost of the IgMFA was estimated at $5700; therefore, the ICER to have one additional treatment success was estimated to be $1579. The key drivers for the ICER were the relative sensitivity of IgMFA versus clinical diagnosis, the cost of IgMFA, and the prevalence of typhoid fever or multi-drug resistant strains. The IgMFA was more costly but more effective than the clinical diagnosis in the base-case analysis. An IgMFA could be more cost-effective than the base-case if the sensitivity of IgMFA was higher or cost lower. Decision makers may use a willingness-to-pay threshold that considers the additional cost of hospitalisation for treatment failures.Author summary: Typhoid fever is a common disease among children in Cambodia. It can be fatal or lead to chronic faecal carriage if not treated. In resource-limited settings, typhoid fever is often diagnosed and treated presumptively. This study evaluated the cost-effectiveness of introducing a rapid diagnostic test for typhoid fever in a remote setting in Cambodia. In a hypothetical cohort with 1000 children in each arm we compared the use of a rapid diagnostic test (RDT) with a presumptive clinical diagnosis. In each arm, we calculated the number of true-positive typhoid fever cases detected, treatment success at seven days, and the cost of making a correct diagnosis and providing the correct treatment. The RDT detected 5.87 more true positives, had 3.61 more treatment successful cases, but the total cost was $ 5700 higher per 1000 children. Additional analysis showed that the RDT would be more cost-effective if the sensitivity could be improved or cost lowered.

Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0006961 (text/html)
https://journals.plos.org/plosntds/article/file?id ... 06961&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pntd00:0006961

DOI: 10.1371/journal.pntd.0006961

Access Statistics for this article

More articles in PLOS Neglected Tropical Diseases from Public Library of Science
Bibliographic data for series maintained by plosntds ().